Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment

In current clinical practices, up to 27% of all breast cancer patients receive neoadjuvant chemotherapy. High pathological complete response rate is frequently associated with tumor-infiltrating lymphocytes. Additionally, circulating immune cells are also often linked to chemotherapy response. We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Onesti, Concetta Elisa, Josse, Claire, Poncin, Aurélie, Frères, Pierre, Poulet, Christophe, Bours, Vincent, Jerusalem, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154746/
https://www.ncbi.nlm.nih.gov/pubmed/30263098
http://dx.doi.org/10.18632/oncotarget.26120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154746/
https://www.ncbi.nlm.nih.gov/pubmed/30263098
http://dx.doi.org/10.18632/oncotarget.26120

Ejemplares similares